Etanercept Suppresses Arteritis in a Murine Model of Kawasaki Disease: A Comparative Study Involving Different Biological Agents

Figure 2

Effects of different biological agents on the development of vasculitis. (a) Incidence of panvasculitis (%), (b) number of segments with arteritis, (c) severity score, and (d) total area of inflammation (mm²). Data at 2 weeks are indicated by white bars and those at 4 weeks by black bars. ^#𝑃<0.001 versus control, *𝑃<0.05 versus CAWS, **𝑃<0.001 versus CAWS. Abbreviations: control (Con), CAWS with no drug treatment (CAWS), immunoglobulin (IVIG), etanercept (EC), methylprednisolone (MP), and cyclosporine-A (CsA).

(a)

(b)

(c)

(d)